Clinical Centers of Excellence: Prostate Cancer

Quality medical care can be found in every specialty in any corner of the country, but some clinical centers rise above the pack.

Some institutions are known throughout the medical community for their overall expertise, but we saw a need for a physician’s guide to the best in various specialties. This is the third in Medical Economics’ monthly series: Clinical Centers of Excellence.

The purpose is to recognize those institutions that bring something extra to a specialty, whether through research, patient care, community outreach-or all of these areas.

We’ve chosen the centers based on information from key opinion leaders in various specialties and through physician surveys. To help choose the Clinical Centers of Excellence in prostate cancer, we surveyed readers of Urology Times and spoke with prostate cancer KOLs. We then asked the centers to report data and other information, which was verified whenever possible.

Geography is a factor as well: Patients, after all, are more likely to visit a center that is nearby rather than one across the country.

This series provides physicians with a valuable tool when considering where to refer challenging cases.

The institutions profiled in this issue-the Cleveland Clinic, Johns Hopkins Medical Institutions, the Mayo Clinic, and Memorial Sloan-Kettering Cancer Center-have prostate cancer programs that are among the finest in the country. We do not rank the centers relative to each other, but explain what makes each one unique. Though we could not profile them all, we have included a list of the other Clinical Centers of Excellence identified by our surveys and KOLs.

Cedars-Sinai Medical Center, Los Angeles, California

Cleveland Clinic, Cleveland, Ohio

Duke University Medical Center, Durham, North Carolina

Johns Hopkins Medical Institutions, Baltimore, Maryland

Loyola University Medical Center, Chicago, Illinois

Mayo Clinic, Rochester, Minnesota

Memorial Sloan-Kettering Cancer Center, New York, New York

University of California, San Francisco Medical Center, San Francisco, California

University of Iowa Holden Comprehensive Cancer Center, Iowa City, Iowa

University of Kansas Medical Center, Kansas City, Kansas

University of Texas M.D. Anderson Cancer Center, Houston, Texas

Vanderbilt University Medical Center, Nashville, Tennessee

Washington University Medical Center, St. Louis, Missouri

 

Advanstar Clinical Centers of Excellence
Institutions under consideration to be named Clinical Centers of Excellence are asked to self-report data, which is checked against publicly available information. Depending on the specialty, these criteria may include:

Quality-improvement initiatives under way

Community outreach

National awards and recognition

Participation in national therapeutic initiatives (e.g., the National Cancer Consortium, Children’s Oncology Group, etc.)

Number of referrals for the particular specialty area

Number of international referrals

Number of patients treated/procedures performed per year

Number of research protocols engaged in annually

Number of medication/surgical errors

Systems in place to prevent errors

Outcomes data (e.g., mortality/morbidity rates, unnecessary readmission rates, etc.)

Level of technological equipment on site

EHR processes and level of development

Participation in regional systems integration initiatives

Follow-up care programs (e.g., enforcement of secondary prevention/medication compliance)

Patient education efforts

Patient satisfaction survey results

Infectious disease prevention efforts

Availability of comprehensive care programs (e.g., preventive cardiology)

Evidence of incorporating research and clinical care

 High ranking by NCQA

KOL publishing records

Medical Nobel Laureates on faculty

JCAHO certification/accreditation